In the latest session, Allogene Therapeutics Inc (NASDAQ: ALLO) closed at $3.80 down -4.76% from its previous closing price of $3.99. On the day, 2882301 shares were traded.
Ratios:
For a deeper understanding of Allogene Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.58 and its Current Ratio is at 12.58. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.18.
On December 08, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $7.Citigroup initiated its Buy rating on December 08, 2023, with a $7 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 30 ’24 when Parker Geoffrey M. bought 190 shares for $3.60 per share. The transaction valued at 683 led to the insider holds 819,590 shares of the business.
MESSEMER DEBORAH M. sold 18,640 shares of ALLO for $50,317 on Dec 18 ’23. The Director now owns 62,456 shares after completing the transaction at $2.70 per share. On Aug 07 ’23, another insider, Mayo Stephen, who serves as the Director of the company, sold 10,000 shares for $4.29 each. As a result, the insider received 42,855 and left with 25,328 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4015.89 while its Price-to-Book (P/B) ratio in mrq is 1.10.
Stock Price History:
Over the past 52 weeks, ALLO has reached a high of $6.89, while it has fallen to a 52-week low of $2.23.
Shares Statistics:
A total of 169.09M shares are outstanding, with a floating share count of 104.72M. Insiders hold about 38.07% of the company’s shares, while institutions hold 60.82% stake in the company.
Earnings Estimates
There are European Union Allowance (EUA) different market analysts currently analyzing its stock. The consensus estimate for the next quarter is $166.81, with high estimates of $2.07 and low estimates of $37.23.
Analysts are recommending an EPS of between $Basic Materials and $Financial Services for the fiscal current year, implying an average EPS of $Financial Services. EPS for the following year is $Stocks, with Future analysts recommending between $Stocks and $Stocks.
